 Marisa Friederich
Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondrial Diseases | 6 | 2025 | 92 | 2.330 |
Why?
| | Mitochondrial Proteins | 8 | 2025 | 262 | 1.640 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 5 | 2025 | 23 | 1.610 |
Why?
| | Cardiomyopathies | 4 | 2024 | 334 | 1.490 |
Why?
| | Mitochondria | 15 | 2025 | 984 | 1.270 |
Why?
| | DNA, Mitochondrial | 7 | 2025 | 212 | 1.220 |
Why?
| | Leigh Disease | 5 | 2025 | 22 | 1.170 |
Why?
| | Electron Transport Complex I | 3 | 2022 | 42 | 1.140 |
Why?
| | Acidosis, Lactic | 4 | 2024 | 45 | 1.060 |
Why?
| | Mutation | 13 | 2025 | 4081 | 1.020 |
Why?
| | Hyperglycinemia, Nonketotic | 6 | 2026 | 56 | 0.920 |
Why?
| | Fibroblasts | 6 | 2025 | 1019 | 0.900 |
Why?
| | Oxidative Phosphorylation | 6 | 2025 | 209 | 0.850 |
Why?
| | Adenosine Triphosphate | 1 | 2025 | 501 | 0.760 |
Why?
| | NADH Dehydrogenase | 2 | 2019 | 20 | 0.660 |
Why?
| | Protein Biosynthesis | 2 | 2021 | 455 | 0.660 |
Why?
| | Protein Subunits | 2 | 2018 | 228 | 0.650 |
Why?
| | Ribosomal Proteins | 1 | 2021 | 94 | 0.650 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 10 | 0.630 |
Why?
| | Quinone Reductases | 1 | 2020 | 17 | 0.630 |
Why?
| | Leukoencephalopathies | 1 | 2019 | 24 | 0.610 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 48 | 0.600 |
Why?
| | Diseases in Twins | 1 | 2019 | 115 | 0.580 |
Why?
| | Nitrogenous Group Transferases | 1 | 2018 | 2 | 0.570 |
Why?
| | Glycine | 4 | 2026 | 186 | 0.560 |
Why?
| | Thalamus | 1 | 2019 | 127 | 0.550 |
Why?
| | Infant Nutrition Disorders | 1 | 2017 | 10 | 0.510 |
Why?
| | Brain Diseases | 3 | 2022 | 152 | 0.410 |
Why?
| | RNA, Transfer, Phe | 3 | 1998 | 9 | 0.380 |
Why?
| | RNA, Transfer | 4 | 2020 | 144 | 0.330 |
Why?
| | Infant, Newborn | 12 | 2024 | 6399 | 0.330 |
Why?
| | Nucleic Acid Conformation | 4 | 1998 | 728 | 0.320 |
Why?
| | Saccharomyces cerevisiae | 4 | 2018 | 579 | 0.300 |
Why?
| | Epilepsy | 4 | 2019 | 386 | 0.300 |
Why?
| | Infant | 12 | 2024 | 10023 | 0.270 |
Why?
| | Serine | 2 | 2026 | 142 | 0.260 |
Why?
| | Electron Transport Complex IV | 3 | 2025 | 62 | 0.250 |
Why?
| | Phenotype | 4 | 2024 | 3147 | 0.240 |
Why?
| | Cytochrome-c Oxidase Deficiency | 1 | 2025 | 4 | 0.230 |
Why?
| | Hydrolysis | 1 | 2025 | 198 | 0.220 |
Why?
| | Dichloroacetic Acid | 1 | 2024 | 7 | 0.220 |
Why?
| | Bezafibrate | 1 | 2024 | 10 | 0.210 |
Why?
| | Acyl-CoA Dehydrogenases | 1 | 2024 | 12 | 0.210 |
Why?
| | Folic Acid | 1 | 2026 | 198 | 0.210 |
Why?
| | Pyridinium Compounds | 1 | 2024 | 31 | 0.210 |
Why?
| | Iron-Sulfur Proteins | 2 | 2022 | 47 | 0.200 |
Why?
| | Alagille Syndrome | 1 | 2024 | 29 | 0.200 |
Why?
| | Niacinamide | 1 | 2024 | 87 | 0.200 |
Why?
| | Humans | 34 | 2026 | 144667 | 0.200 |
Why?
| | Growth Differentiation Factor 15 | 1 | 2024 | 41 | 0.200 |
Why?
| | Male | 24 | 2026 | 72431 | 0.200 |
Why?
| | Genetic Variation | 2 | 2021 | 985 | 0.190 |
Why?
| | Liver Failure, Acute | 1 | 2023 | 67 | 0.180 |
Why?
| | Pedigree | 3 | 2018 | 515 | 0.180 |
Why?
| | Nervous System Diseases | 1 | 2025 | 285 | 0.180 |
Why?
| | Biliary Atresia | 1 | 2024 | 158 | 0.180 |
Why?
| | Calcium Channels | 1 | 2022 | 155 | 0.170 |
Why?
| | Magnetic Resonance Imaging | 5 | 2020 | 3888 | 0.170 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2024 | 265 | 0.160 |
Why?
| | Skin | 1 | 2025 | 762 | 0.160 |
Why?
| | Muscular Diseases | 1 | 2020 | 108 | 0.160 |
Why?
| | External Capsule | 1 | 2019 | 3 | 0.160 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 828 | 0.150 |
Why?
| | Tyrosine | 1 | 2020 | 219 | 0.150 |
Why?
| | Cells, Cultured | 2 | 2025 | 4110 | 0.150 |
Why?
| | Anticodon | 3 | 1997 | 24 | 0.150 |
Why?
| | Alleles | 2 | 2025 | 886 | 0.150 |
Why?
| | Amino Acid Sequence | 3 | 2018 | 2136 | 0.150 |
Why?
| | Homozygote | 1 | 2020 | 200 | 0.150 |
Why?
| | Corpus Callosum | 1 | 2019 | 72 | 0.150 |
Why?
| | Iron | 1 | 2022 | 358 | 0.150 |
Why?
| | Twins, Monozygotic | 1 | 2019 | 134 | 0.150 |
Why?
| | Pipecolic Acids | 1 | 2019 | 24 | 0.150 |
Why?
| | Female | 16 | 2025 | 78304 | 0.140 |
Why?
| | Kinetics | 2 | 2020 | 1602 | 0.140 |
Why?
| | Eye | 1 | 2019 | 110 | 0.140 |
Why?
| | Taurine | 1 | 2019 | 41 | 0.140 |
Why?
| | Amino Acyl-tRNA Synthetases | 2 | 2017 | 32 | 0.140 |
Why?
| | Cystathionine beta-Synthase | 1 | 2019 | 65 | 0.140 |
Why?
| | Biomarkers | 5 | 2024 | 4261 | 0.140 |
Why?
| | Oxidation-Reduction | 2 | 2020 | 1078 | 0.140 |
Why?
| | Lentivirus | 1 | 2018 | 61 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4539 | 0.140 |
Why?
| | Models, Molecular | 3 | 2018 | 1610 | 0.140 |
Why?
| | Homocystinuria | 1 | 2019 | 62 | 0.140 |
Why?
| | Lactic Acid | 1 | 2019 | 303 | 0.140 |
Why?
| | Nerve Degeneration | 1 | 2018 | 48 | 0.140 |
Why?
| | Metalloendopeptidases | 1 | 2018 | 63 | 0.140 |
Why?
| | Phenylalanine-tRNA Ligase | 1 | 2017 | 2 | 0.130 |
Why?
| | Spastic Paraplegia, Hereditary | 1 | 2017 | 12 | 0.130 |
Why?
| | White Matter | 1 | 2019 | 153 | 0.130 |
Why?
| | Peptide Elongation Factor G | 1 | 2017 | 1 | 0.130 |
Why?
| | Neonatal Screening | 1 | 2019 | 179 | 0.130 |
Why?
| | Catalytic Domain | 1 | 2018 | 231 | 0.130 |
Why?
| | Mutation, Missense | 3 | 2025 | 338 | 0.130 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2019 | 625 | 0.130 |
Why?
| | Child, Preschool | 7 | 2025 | 11790 | 0.130 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2017 | 46 | 0.130 |
Why?
| | Methylmalonic Acid | 1 | 2017 | 66 | 0.130 |
Why?
| | RNA Splice Sites | 1 | 2017 | 52 | 0.120 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2017 | 25 | 0.120 |
Why?
| | Energy Metabolism | 2 | 2015 | 927 | 0.120 |
Why?
| | Magnesium | 1 | 1997 | 155 | 0.120 |
Why?
| | Metabolic Diseases | 1 | 2018 | 114 | 0.120 |
Why?
| | Vitamin B 12 Deficiency | 1 | 2017 | 78 | 0.120 |
Why?
| | Sodium Benzoate | 1 | 2016 | 5 | 0.120 |
Why?
| | Intestinal Pseudo-Obstruction | 1 | 2016 | 8 | 0.120 |
Why?
| | Mitochondrial Encephalomyopathies | 1 | 2016 | 9 | 0.120 |
Why?
| | Calcium | 1 | 2022 | 1182 | 0.120 |
Why?
| | Congenital Abnormalities | 1 | 2017 | 104 | 0.120 |
Why?
| | Dextromethorphan | 1 | 2016 | 24 | 0.120 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 49 | 0.120 |
Why?
| | Myocardium | 2 | 2018 | 928 | 0.120 |
Why?
| | Liver Transplantation | 1 | 2023 | 826 | 0.120 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2016 | 96 | 0.110 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2016 | 107 | 0.110 |
Why?
| | Acyl Coenzyme A | 1 | 2015 | 32 | 0.110 |
Why?
| | Family | 1 | 2020 | 685 | 0.110 |
Why?
| | 3-Hydroxyacyl CoA Dehydrogenases | 1 | 2015 | 9 | 0.110 |
Why?
| | Acetyl-CoA C-Acetyltransferase | 1 | 2015 | 9 | 0.110 |
Why?
| | Siblings | 1 | 2016 | 195 | 0.110 |
Why?
| | Lipid Metabolism, Inborn Errors | 1 | 2015 | 20 | 0.110 |
Why?
| | Gene Expression | 2 | 2017 | 1476 | 0.110 |
Why?
| | Cell Line | 1 | 2019 | 2821 | 0.100 |
Why?
| | Sulfurtransferases | 1 | 2013 | 9 | 0.100 |
Why?
| | Glutaredoxins | 1 | 2013 | 15 | 0.100 |
Why?
| | Spasm | 1 | 2013 | 21 | 0.100 |
Why?
| | Time-to-Treatment | 1 | 2016 | 242 | 0.100 |
Why?
| | Child | 12 | 2025 | 22600 | 0.100 |
Why?
| | Mice, Inbred C57BL | 1 | 2024 | 5967 | 0.100 |
Why?
| | Proteins | 2 | 2022 | 1016 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2137 | 0.090 |
Why?
| | Child Development | 2 | 2016 | 482 | 0.090 |
Why?
| | Brain | 5 | 2026 | 2934 | 0.090 |
Why?
| | Electron Transport | 3 | 2018 | 115 | 0.090 |
Why?
| | Base Sequence | 4 | 2018 | 2177 | 0.080 |
Why?
| | Sirtuin 3 | 1 | 2011 | 58 | 0.080 |
Why?
| | Proteomics | 3 | 2024 | 1183 | 0.080 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2909 | 0.070 |
Why?
| | Transcription, Genetic | 1 | 2015 | 1468 | 0.070 |
Why?
| | Fatty Liver | 1 | 2011 | 250 | 0.070 |
Why?
| | Aminoacylation | 2 | 2017 | 14 | 0.060 |
Why?
| | Glycine Dehydrogenase (Decarboxylating) | 1 | 2026 | 13 | 0.060 |
Why?
| | Heterozygote | 2 | 2017 | 313 | 0.060 |
Why?
| | Exome | 2 | 2017 | 227 | 0.060 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2024 | 10 | 0.050 |
Why?
| | Animals | 6 | 2026 | 37948 | 0.050 |
Why?
| | Introns | 1 | 2024 | 255 | 0.050 |
Why?
| | Age of Onset | 1 | 2025 | 551 | 0.050 |
Why?
| | Hydrocephalus | 1 | 2024 | 111 | 0.050 |
Why?
| | Cell Respiration | 2 | 2015 | 105 | 0.050 |
Why?
| | Drug Combinations | 1 | 2024 | 393 | 0.050 |
Why?
| | Liver | 2 | 2026 | 1889 | 0.050 |
Why?
| | Fibroblast Growth Factors | 1 | 2024 | 188 | 0.050 |
Why?
| | Threonine | 1 | 2022 | 44 | 0.050 |
Why?
| | Carbon-Sulfur Lyases | 1 | 2022 | 14 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2022 | 273 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2025 | 326 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2024 | 890 | 0.040 |
Why?
| | Sulfur | 1 | 2022 | 64 | 0.040 |
Why?
| | Echocardiography | 1 | 2024 | 644 | 0.040 |
Why?
| | Oxidative Stress | 2 | 2019 | 1338 | 0.040 |
Why?
| | Mice | 3 | 2026 | 18261 | 0.040 |
Why?
| | Hippocampus | 1 | 2026 | 966 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2020 | 303 | 0.040 |
Why?
| | Nucleic Acid Heteroduplexes | 2 | 1995 | 9 | 0.040 |
Why?
| | Muscle, Skeletal | 2 | 2020 | 1788 | 0.040 |
Why?
| | Homocysteine | 1 | 2019 | 152 | 0.030 |
Why?
| | Dermis | 1 | 2018 | 31 | 0.030 |
Why?
| | Homeostasis | 1 | 2022 | 639 | 0.030 |
Why?
| | Critical Illness | 1 | 2024 | 888 | 0.030 |
Why?
| | Amino Acids | 1 | 2022 | 521 | 0.030 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 46 | 0.030 |
Why?
| | Intelligence Tests | 2 | 2016 | 55 | 0.030 |
Why?
| | Brachial Artery | 1 | 2019 | 206 | 0.030 |
Why?
| | Nucleic Acid Denaturation | 1 | 1997 | 32 | 0.030 |
Why?
| | Yeasts | 1 | 1997 | 51 | 0.030 |
Why?
| | Chromatography, Liquid | 1 | 2019 | 444 | 0.030 |
Why?
| | RNA, Double-Stranded | 1 | 1997 | 56 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 552 | 0.030 |
Why?
| | Molecular Structure | 1 | 1998 | 495 | 0.030 |
Why?
| | Muscular Dystrophy, Oculopharyngeal | 1 | 2016 | 1 | 0.030 |
Why?
| | RNA, Transfer, Lys | 1 | 1995 | 3 | 0.030 |
Why?
| | Ophthalmoplegia | 1 | 2016 | 13 | 0.030 |
Why?
| | Magnesium Chloride | 1 | 1995 | 7 | 0.030 |
Why?
| | Enoyl-CoA Hydratase | 1 | 2015 | 12 | 0.030 |
Why?
| | Delayed Diagnosis | 1 | 2016 | 98 | 0.030 |
Why?
| | Dyskinesias | 1 | 2015 | 20 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2018 | 269 | 0.030 |
Why?
| | RNA, Fungal | 1 | 1995 | 73 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2016 | 249 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2017 | 717 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2015 | 371 | 0.030 |
Why?
| | Hot Temperature | 1 | 1997 | 410 | 0.030 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2015 | 93 | 0.030 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2018 | 418 | 0.030 |
Why?
| | Plasmids | 1 | 1995 | 375 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2015 | 409 | 0.030 |
Why?
| | Muscles | 1 | 2015 | 332 | 0.030 |
Why?
| | Young Adult | 2 | 2022 | 14122 | 0.020 |
Why?
| | RNA | 2 | 1997 | 926 | 0.020 |
Why?
| | Atrophy | 1 | 2013 | 199 | 0.020 |
Why?
| | Fatal Outcome | 1 | 2013 | 305 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1501 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1134 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 5870 | 0.020 |
Why?
| | Acetylation | 1 | 2011 | 249 | 0.020 |
Why?
| | Adolescent | 3 | 2019 | 22409 | 0.020 |
Why?
| | Adult | 2 | 2025 | 40489 | 0.020 |
Why?
| | Inflammation | 1 | 2019 | 2870 | 0.020 |
Why?
| | Time Factors | 2 | 1995 | 7140 | 0.020 |
Why?
| | Lipid Metabolism | 1 | 2011 | 524 | 0.020 |
Why?
| | Jaw Abnormalities | 1 | 1967 | 3 | 0.020 |
Why?
| | Rats | 1 | 2016 | 5570 | 0.020 |
Why?
| | Malocclusion | 1 | 1967 | 22 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2922 | 0.010 |
Why?
| | Colorado | 1 | 2016 | 4558 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2011 | 3109 | 0.010 |
Why?
| | Diet | 1 | 2011 | 1270 | 0.010 |
Why?
| | United States | 1 | 2019 | 16018 | 0.010 |
Why?
| | Birefringence | 1 | 1995 | 7 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 324 | 0.010 |
Why?
| | Personality Assessment | 1 | 1967 | 79 | 0.000 |
Why?
| | Psychological Tests | 1 | 1967 | 132 | 0.000 |
Why?
| | Mother-Child Relations | 1 | 1967 | 132 | 0.000 |
Why?
|
|
Friederich's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|